Answer
Kadcyla (trastuzumab emtansine) vial labels must be checked to prevent medication errors by ensuring that Kadcyla, rather than another trastuzumab-containing product such as trastuzumab or trastuzumab deruxtecan, is prepared and administered.
Sources for this answer
- Kadcyla 100 mg and 160 mg Powder for Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 18Document updated
Sources checked